- Report
- February 2026
- 486 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 281 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 374 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 382 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 384 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 273 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 375 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 484 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 274 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 166 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 296 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 342 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 378 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 383 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 373 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 466 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 565 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 379 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 405 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 469 Pages
Global
From €5102EUR$5,850USD£4,425GBP

The Biotechnology market has been affected by the pandemic in a variety of ways. Companies in the sector have had to adjust their operations to meet the demands of the new environment. Many have shifted their focus to developing treatments and vaccines for the virus, while others have had to pivot their operations to meet the needs of the changing market. Companies have also had to adjust their supply chains to ensure the safety of their products and services.
The pandemic has also had an impact on the financial performance of biotechnology companies. Many have seen their stock prices decline due to the uncertainty of the market. Additionally, the pandemic has caused a decrease in research and development spending, as well as a decrease in venture capital investments.
Notable companies in the biotechnology market include Gilead Sciences, Moderna, Regeneron Pharmaceuticals, and Novavax. These companies have all been involved in the development of treatments and vaccines for the virus. Additionally, they have all seen their stock prices increase due to the pandemic. Show Less Read more